Back to Report Store Home

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

  • Published: Apr-2018
  • Report Code: GBIHC029IDB
  • Report Format: pdf

Description

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 Cognitive Impairment Disorders Report Coverage

3.2 Cognitive Impairment Associated With Schizophrenia (CIAS) – Overview

3.3 Dementia – Overview

3.4 Mild Cognitive Impairment – Overview

3.5 Alzheimer's Disease – Overview

3.6 GBI Research Report Guidance

4 Therapeutics Development

4.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

4.2 Dementia

4.3 Mild Cognitive Impairment

4.4 Alzheimer's Disease

5 Therapeutics Assessment

5.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

5.2 Dementia

5.3 Mild Cognitive Impairment

5.4 Alzheimer's Disease

6 Companies Involved in Therapeutics Development

6.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

6.2 Dementia

6.3 Mild Cognitive Impairment

6.4 Alzheimer's Disease

7 Dormant Projects

7.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

7.2 Dementia

7.3 Mild Cognitive Impairment

7.4 Alzheimer's Disease

8 Discontinued Products

8.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

8.2 Dementia

8.3 Mild Cognitive Impairment

8.4 Alzheimer's Disease

9 Product Development Milestones

9.1 Cognitive Impairment Associated With Schizophrenia (CIAS)

9.2 Dementia

9.3 Mild Cognitive Impairment

9.4 Alzheimer's Disease

10 Appendix

10.1 Methodology

10.2 Coverage

10.3 Secondary Research

10.4 Primary Research

10.5 Expert Panel Validation

10.6 Contact Us

10.7 Disclaimer

 
      captcha refresh

I have read and accept terms and conditions and privacy policy

Cancel
License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Request Sample Pages Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards